Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.

Brandenburg JE, Krach LE, Gormley ME Jr.

Am J Phys Med Rehabil. 2013 Oct;92(10):898-904. doi: 10.1097/PHM.0b013e31829231fa.

2.

[Treatment with botulinum toxin in neurologic pediatrics].

Justus N, Lee SH, Berweck S, Heinen F.

Kinderkrankenschwester. 2007 Jul;26(7):274-6. Review. German. No abstract available.

PMID:
17726921
3.

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN.

J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12.

PMID:
24630348
4.

Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.

Kolaski K, Ajizian SJ, Passmore L, Pasutharnchat N, Koman LA, Smith BP.

Am J Phys Med Rehabil. 2008 Jul;87(7):556-66. doi: 10.1097/PHM.0b013e31817c115b.

PMID:
18574347
5.

[Experiences with botulinum toxin injections against spasticity in children].

Ramstad K, Karstensen AB, Risberg K, Bergsaker DK, Sommer FF.

Tidsskr Nor Laegeforen. 2006 Feb 9;126(4):450-2. Norwegian.

6.

The use of botulinum toxin in pediatric disorders.

Gaebler-Spira D, Revivo G.

Phys Med Rehabil Clin N Am. 2003 Nov;14(4):703-25. Review.

PMID:
14580033
7.

Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Schroeder AS, Berweck S, Lee SH, Heinen F.

Neurotox Res. 2006 Apr;9(2-3):189-96. Review.

PMID:
16785117
8.

Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.

Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.

Am J Phys Med Rehabil. 2003 Apr;82(4):284-9.

PMID:
12649654
9.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.

PMID:
19142573
10.

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469. doi: 10.1002/14651858.CD003469.pub4. Review.

PMID:
20091546
11.

Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.

Williams SA, Reid S, Elliott C, Shipman P, Valentine J.

Dev Med Child Neurol. 2013 Sep;55(9):813-20. doi: 10.1111/dmcn.12200. Epub 2013 Jun 22.

12.

Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.

Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.

Dev Med Child Neurol. 2011 Jun;53(6):559-64. doi: 10.1111/j.1469-8749.2011.03952.x. Epub 2011 Mar 17.

13.

Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Thorley M, Donaghey S, Edwards P, Copeland L, Kentish M, McLennan K, Lindsley J, Gascoigne-Pees L, Sakzewski L, Boyd RN.

BMC Pediatr. 2012 Aug 9;12:120. doi: 10.1186/1471-2431-12-120.

14.

Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.

Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.

J Hand Surg Am. 2013 Mar;38(3):435-46.e1. doi: 10.1016/j.jhsa.2012.12.019.

PMID:
23428186
15.

Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.

Blaszczyk I, Foumani NP, Ljungberg C, Wiberg M.

Toxins (Basel). 2015 Nov 6;7(11):4645-54. doi: 10.3390/toxins7114645.

17.

The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy.

Placzek R, Salem KH, Meiss LA, Siebold D, Drescher W.

Acta Orthop Belg. 2012 Feb;78(1):111-6.

PMID:
22523937
18.

Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.

Naidu K, Smith K, Sheedy M, Adair B, Yu X, Graham HK.

Dev Med Child Neurol. 2010 Feb;52(2):139-44. doi: 10.1111/j.1469-8749.2009.03583.x.

19.

Ketamine-based procedural sedation and analgesia for botulinum toxin A injections in children with cerebral palsy.

Chow C, Choong CT.

Eur J Paediatr Neurol. 2016 Mar;20(2):319-22. doi: 10.1016/j.ejpn.2015.11.009. Epub 2015 Nov 27.

PMID:
26640079
20.

Supplemental Content

Support Center